SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-123073
Filing Date
2020-04-28
Accepted
2020-04-28 16:15:39
Documents
7
Period of Report
2020-06-10
Effectiveness Date
2020-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d866498ddef14a.htm DEF 14A 602846
2 GRAPHIC g866498g10v95.jpg GRAPHIC 72198
3 GRAPHIC g866498g11y77.jpg GRAPHIC 26592
4 GRAPHIC g866498g21j11.jpg GRAPHIC 24658
5 GRAPHIC g866498g56z83.jpg GRAPHIC 16586
6 GRAPHIC g866498g57f70.jpg GRAPHIC 22487
7 GRAPHIC g866498g80n98.jpg GRAPHIC 35798
  Complete submission text file 0001193125-20-123073.txt   871561
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38295 | Film No.: 20825184
SIC: 2836 Biological Products, (No Diagnostic Substances)